Induced migration of dental pulp stem cells for in vivo pulp regeneration.

Center for Craniofacial Regeneration (CCR), Fu Foundation School of Engineering and Applied Science, Columbia University Medical Center, Columbia University, 630 W. 168 St. – PH7E-CDM, New York, NY 10032, USA.
Journal of dental research (Impact Factor: 4.14). 05/2011; 90(8):1013-8. DOI: 10.1177/0022034511408426
Source: PubMed

ABSTRACT Dental pulp has intrinsic capacity for self-repair. However, it is not clear whether dental pulp cells can be recruited endogenously for regenerating pulp tissues, including mineralizing into dentin. This work is based on a hypothesis that dental pulp stem/progenitor cells can be induced to migrate by chemotactic cytokines and act as endogenous cell sources for regeneration and mineralization. Dental stem cells (DSCs) were isolated from adult human tooth pulp and seeded on the surfaces of 3D collagen gel cylinders that were incubated in chemically defined media with stromal-derived factor-1α (SDF1), basic fibroblast growth factor (bFGF), or bone morphogenetic protein-7 (BMP7). Significantly more cells were recruited into collagen gel by SDF1 or bFGF than without cytokines in 7 days, whereas BMP7 had little effect on cell recruitment. BMP7, however, was highly effective, equally to dexamethasone, in orchestrating mineralization of cultured DSCs. Cell membrane receptors for SDF1, bFGF, and BMP7 were up-regulated in treated DSCs. Upon in vivo delivery, bFGF induced re-cellularization and re-vascularization in endodontically treated human teeth implanted into the dorsum of rats. Thus, endogenous dental pulp cells, including stem/progenitor cells, may be recruited and subsequently differentiated by chemotaxis of selective cytokines in the regeneration of dental pulp.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction Prostacyclin (PGI2), a member of the prostaglandin family, can promote angiogenesis and cell proliferation. Methods In this study, the effect of the application of a PGI2 analog (iloprost) on dentin repair was examined in vitro and in vivo. Results Iloprost significantly stimulated the expression of vascular endothelial growth factor and osteo-/odontogenic marker messenger RNA in human dental pulp cells (HDPCs) under osteoinductive conditions in vitro. In addition, iloprost enhanced HDPC alkaline phosphatase enzymatic activity and mineral deposition. An in vivo study was performed using a rat molar mechanical pulp exposure model. After 30 days, histologic analysis revealed that there was a dramatic tertiary dentin formation in the iloprost-treated group compared with the calcium hydroxide and the untreated control groups. Furthermore, vascular endothelial growth factor protein expression in dental pulp tissue was increased in the iloprost-treated group as determined by immunohistochemical staining. Conclusions Taken together, the present study, for the first time, shows that iloprost induces the expression of osteo-/odontogenic markers in vitro and promotes angiogenic factor expression and enhances tertiary dentin formation in vivo. This implies the potential clinical usefulness of iloprost in vital pulp therapy.
    Journal of Endodontics 11/2014; DOI:10.1016/j.joen.2014.07.002 · 2.79 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The development of new therapies, the biotherapies, can now be envisioned in dentistry thanks to the important development of research in the stem cell and biomaterial fields. Indeed, the recent discovery of stem cells in different tissues of the body, and in particular in the dental pulp, should allow the development of new therapeutic approaches for pulpo-dentinal lesions. In case of moderate pulp injury, the stimulation by biomolecules of pulp stem cells located in the remaining pulp is the approach to be considered. In case of more severe lesions requiring a total removal of pulp tissues, a cell therapy could be considered. The objective of this article is to present these innovative therapeutic approaches for the future of dentistry.
    British dental journal 06/2014; 216(11):619-21. DOI:10.1038/sj.bdj.2014.450 · 1.08 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The goal of regenerative endodontics is to restore the functions of the dental pulp-dentin complex. Two approaches are being applied toward dental pulp-dentin regeneration: cell transplantation and cell homing. The majority of previous approaches are based on cell transplantation by delivering ex vivo cultivated cells toward dental pulp or dentin regeneration. Many hurdles limit the clinical translation of cell transplantation such as the difficulty of acquiring and isolating viable cells, uncertainty of what cells or what fractions of cells to use, excessive cost of cell manipulation and transportation, and the risk of immune rejection, pathogen transmission, and tumorigenesis in associated with ex vivo cell manipulation. In contrast, cell homing relies on induced chemotaxis of endogenous cells and therefore circumvents many of the difficulties that are associated with cell transplantation. An array of proteins, peptides, and chemical compounds that are yet to be identified may orchestrate endogenous cells to regenerate dental pulp-dentin complex. Both cell transplantation and cell homing are scientifically valid approaches; however, cell homing offers a number of advantages that are compatible with the development of clinical therapies for dental pulp-dentin regeneration.
    Endodontic Topics 03/2013; 28(1):106-117. DOI:10.1111/etp.12037